In a major shift for the American healthcare market, President Donald J. Trump officially launched TrumpRx.gov on February 5, 2026. The platform is designed to bypass traditional insurance middle-men and provide Americans with direct access to “Most-Favored-Nation” (MFN) pricing on high-cost medications.
By connecting patients directly with pharmaceutical manufacturers, the administration aims to lower out-of-pocket costs for some of the most widely used—and expensive—drugs in the United States.
